DE60108627D1 - Cefalosporin-zwischenprodukte - Google Patents

Cefalosporin-zwischenprodukte

Info

Publication number
DE60108627D1
DE60108627D1 DE60108627T DE60108627T DE60108627D1 DE 60108627 D1 DE60108627 D1 DE 60108627D1 DE 60108627 T DE60108627 T DE 60108627T DE 60108627 T DE60108627 T DE 60108627T DE 60108627 D1 DE60108627 D1 DE 60108627D1
Authority
DE
Germany
Prior art keywords
compound
formula
cephalosporin intermediates
cephalosporin
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60108627T
Other languages
English (en)
Other versions
DE60108627T2 (de
Inventor
Peter Kremminger
Johannes Ludescher
Siegfried Wolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of DE60108627D1 publication Critical patent/DE60108627D1/de
Publication of DE60108627T2 publication Critical patent/DE60108627T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60108627T 2000-04-28 2001-04-26 Cefalosporin-zwischenprodukte Expired - Lifetime DE60108627T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0010475.2A GB0010475D0 (en) 2000-04-28 2000-04-28 Organic compounds
GB0010475 2000-04-28
PCT/EP2001/004735 WO2001083491A1 (en) 2000-04-28 2001-04-26 Cephalosporin intermediates

Publications (2)

Publication Number Publication Date
DE60108627D1 true DE60108627D1 (de) 2005-03-03
DE60108627T2 DE60108627T2 (de) 2005-12-29

Family

ID=9890746

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60108627T Expired - Lifetime DE60108627T2 (de) 2000-04-28 2001-04-26 Cefalosporin-zwischenprodukte

Country Status (12)

Country Link
US (1) US6787649B2 (de)
EP (1) EP1278754B1 (de)
JP (1) JP4990462B2 (de)
KR (1) KR100789156B1 (de)
CN (1) CN1195761C (de)
AT (1) ATE287889T1 (de)
AU (1) AU2001260255A1 (de)
CA (1) CA2405621C (de)
DE (1) DE60108627T2 (de)
GB (1) GB0010475D0 (de)
TW (1) TWI281920B (de)
WO (1) WO2001083491A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101045733B (zh) * 2007-01-26 2011-11-16 浙江永宁药业股份有限公司 一种头孢替安盐酸盐制备方法
CN101633666B (zh) * 2009-08-26 2010-08-18 海南永田药物研究院有限公司 一种盐酸头孢替安化合物及其新制法
CN102190667B (zh) 2011-03-24 2013-05-29 海南灵康制药有限公司 一种纯化盐酸头孢替安的制法
CN102898441A (zh) * 2012-10-11 2013-01-30 南通康鑫药业有限公司 一种头孢替安的合成方法
CN102977123B (zh) * 2012-12-03 2015-04-29 邓世碧 一种头孢类化合物及其药学可接受盐
CN103012436B (zh) * 2012-12-04 2015-07-01 山东鑫泉医药有限公司 头孢替安盐酸盐的制备方法
CN103232477B (zh) * 2013-05-08 2014-04-09 四川省惠达药业有限公司 一种盐酸头孢替安化合物、其制备方法及其药物组合物
CN103601737B (zh) * 2013-12-04 2016-02-03 哈药集团制药总厂 一种盐酸头孢替安的制备方法
CN105125558A (zh) * 2015-09-18 2015-12-09 青岛华之草医药科技有限公司 一种抗菌药物盐酸头孢替安组合物
CN105820162B (zh) * 2016-05-12 2019-01-08 浙江永宁药业股份有限公司 一种头孢替安工艺杂质的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341775A (en) * 1978-09-11 1982-07-27 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
EP0088454B1 (de) * 1979-09-03 1986-03-05 Fujisawa Pharmaceutical Co., Ltd. Ausgangsprodukte für die Herstellung von Cephalosporinderivaten und Verfahren zu ihrer Herstellung
NZ208281A (en) 1983-06-02 1986-11-12 Takeda Chemical Industries Ltd Cephalosporin ester derivatives and pharmaceutical compositions
JPS6011490A (ja) * 1983-06-24 1985-01-21 Sagami Chem Res Center β−ラクタム誘導体
IT1265341B1 (it) 1993-07-16 1996-11-22 Farmabios Srl Procedimento per la preparazione di cefalosporine
AU4123396A (en) * 1994-12-09 1996-06-26 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and pharmaceutical use thereof

Also Published As

Publication number Publication date
AU2001260255A1 (en) 2001-11-12
TWI281920B (en) 2007-06-01
US20030153748A1 (en) 2003-08-14
KR100789156B1 (ko) 2007-12-28
WO2001083491A1 (en) 2001-11-08
CN1195761C (zh) 2005-04-06
JP2003531911A (ja) 2003-10-28
GB0010475D0 (en) 2000-06-14
CA2405621C (en) 2009-12-15
DE60108627T2 (de) 2005-12-29
EP1278754A1 (de) 2003-01-29
US6787649B2 (en) 2004-09-07
CA2405621A1 (en) 2001-11-08
ATE287889T1 (de) 2005-02-15
CN1426416A (zh) 2003-06-25
JP4990462B2 (ja) 2012-08-01
EP1278754B1 (de) 2005-01-26
KR20030005274A (ko) 2003-01-17

Similar Documents

Publication Publication Date Title
SE0000540D0 (sv) New compounds
CY1107634T1 (el) Φαρμακευτικη συνθεση
CR8051A (es) Compuestos farmaceuticos novedosos
CR8475A (es) Fenilalanina-amidas sustituidas por benzoilo
UY28625A1 (es) Nuevos compuestos farmacéuticos
CY1113362T1 (el) Διαρυλ-αιθερες, ως ανταγωνιστης οπιοειδους υποδοχεως
CY1107886T1 (el) Αναστολεις κινασης ως θεραπευτικοι παραγοντες
BR0214268A (pt) Aperfeiçoamentos em relação a abrilhantadores ópticos
CY1106132T1 (el) Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου
CY1113648T1 (el) Παραγωγα πυριδινονης για θεραπεια αθηροσκληρωσης
ATE491703T1 (de) Phthalazinonderivate
DOP2001000151A (es) Derivados de imidazopirimidina y derivados de triazolopimidina.
ATE469645T1 (de) Auf glycinnitril basierende hemmer der dipeptidylpeptidase iv
ATE506354T1 (de) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
CY1113657T1 (el) Νεα παραγωγα βενζοφαινονης ή αλατα αυτων
DE60108627D1 (de) Cefalosporin-zwischenprodukte
ATE235462T1 (de) Metalloproteinase-inhibitoren
DK1181294T3 (da) Hidtil ukendte derivater og analoger af galanthamin
ME00089B (me) Postupak za produkciju beraprosta i njegovih soli
DOP2002000371A (es) Fenil-heterociclil-eteres
BRPI0416678A (pt) pirazolpirimidinas
DE60041001D1 (de) Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien
DK1206452T3 (da) Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser
DK1255745T3 (da) Syntese af vandoplöseligt 9-dihydro-paclitaxel afledninger fra 9-dihydro-13-acetylbaccatin III
DE69715417D1 (de) Oxazolidinester

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN